Prestige Consumer (PBH) Q1 2026 Earnings Report

In Q1 2026, Prestige Consumer Healthcare Inc reported revenues of approximately $249.5 million, marking a 6.6% decline year-over-year primarily due to significant supply chain challenges in its eye care segment, particularly for its flagship product, Clear Eyes. Despite the revenue miss against prior guidance of $258-$260 million, the company achieved gross margins of 56.2%, enhanced by continued cost-saving efforts. EPS remained resilient at $0.95, reflecting a 6% improvement versus the prior year's adjusted EPS of $0.90. Management expressed commitment to strategizing around supply chain disruptions, notably with the acquisition of Pillar5 to bolster production capabilities. The company anticipates recovery in the second half of the fiscal year as supply improves.